Yicheng Ni Selected Research

rhein

1/2021	Design and Evaluation of Rhein-Based MRI Contrast Agents for Visualization of Tumor Necrosis Induced by Combretastatin A-4 Disodium Phosphate.
11/2020	Discovery of necrosis avidity of rhein and its applications in necrosis imaging.
12/2019	Rhein-based necrosis-avid MRI contrast agents for early evaluation of tumor response to microwave ablation therapy.
11/2018	Synthesis and Biological Evaluation of Rhein-Based MRI Contrast Agents for in Vivo Visualization of Necrosis.
1/2017	Radiolabeled Rhein as Small-Molecule Necrosis Avid Agents for Imaging of Necrotic Myocardium.
2/2016	Discovery of Radioiodinated Monomeric Anthraquinones as a Novel Class of Necrosis Avid Agents for Early Imaging of Necrotic Myocardium.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yicheng Ni Research Topics

Disease

79	Necrosis 03/2022 - 02/2002
79	Neoplasms (Cancer) 01/2022 - 01/2002
19	Myocardial Infarction 03/2022 - 02/2002
11	Infarction (Infarctions) 03/2022 - 02/2002
10	Rhabdomyosarcoma 01/2020 - 08/2005
6	Residual Neoplasm 12/2019 - 11/2005
5	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2008
4	Hepatic Infarction 01/2011 - 05/2006
3	Hepatocellular Carcinoma (Hepatoma) 03/2021 - 08/2017
3	Hyperlipidemias (Hyperlipidemia) 08/2015 - 12/2013
3	Atherosclerosis 02/2011 - 10/2008
3	Stroke (Strokes) 01/2009 - 10/2004
2	COVID-19 12/2020 - 01/2020
2	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2016
2	Breast Neoplasms (Breast Cancer) 01/2018 - 11/2015
2	Fibrosis (Cirrhosis) 08/2017 - 10/2010
2	Gallstones (Gallstone) 06/2016 - 12/2013
2	Obesity 08/2015 - 05/2015
1	Rheumatic Diseases (Rheumatism) 12/2020
1	Thyroid Neoplasms (Thyroid Cancer) 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Liver Neoplasms (Liver Cancer) 01/2020

Drug/Important Bio-Agent (IBA)

36	hypericinIBA 03/2022 - 09/2003
21	Contrast MediaIBA 01/2021 - 02/2002
20	fosbretabulin (combretastatin A4)IBA 03/2021 - 03/2005
16	Pharmaceutical PreparationsIBA 01/2022 - 08/2005
9	Biological ProductsIBA 01/2021 - 11/2007
8	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2017
8	Biomarkers (Surrogate Marker)IBA 01/2020 - 08/2010
8	Ethanol (Ethyl Alcohol)IBA 01/2018 - 07/2007
7	combretastatinIBA 01/2019 - 03/2005
6	rheinIBA 01/2021 - 02/2016
6	Therapeutic UsesIBA 10/2015 - 03/2005
6	iodohydroxybenzylpindololIBA 05/2015 - 11/2011
5	Iodine-131IBA 04/2021 - 12/2013
5	GadoliniumIBA 12/2019 - 05/2005
5	RadiopharmaceuticalsIBA 02/2016 - 01/2013
5	triphenyltetrazoliumIBA 12/2015 - 02/2002
4	Indicators and Reagents (Reagents)IBA 01/2018 - 01/2008
4	Gadolinium DTPA (Magnevist)FDA Link 06/2015 - 12/2004
4	pamoic acidIBA 08/2013 - 03/2007
4	N-acetylcochinol-O-phosphateIBA 01/2012 - 08/2010
3	IodineIBA 03/2022 - 09/2011
3	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 04/2021 - 08/2013
3	Phosphates (Orthophosphate)IBA 01/2021 - 01/2016
3	AnthraquinonesIBA 11/2020 - 01/2016
3	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2020 - 06/2013
3	TubulinIBA 01/2020 - 01/2011
3	Trinitrotoluene (TNT)IBA 12/2015 - 11/2011
3	Antineoplastic Agents (Antineoplastics)IBA 10/2015 - 04/2008
3	LipidsIBA 05/2015 - 05/2006
3	CholesterolIBA 12/2013 - 07/2009
3	Pentetic Acid (DTPA)FDA LinkGeneric 06/2013 - 11/2007
2	phosphatidylethanolamineIBA 01/2022 - 01/2013
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2020 - 01/2020
2	gadolinium 1,4,7,10- tetraazacyclododecane- N,N',N'',N'''- tetraacetateIBA 01/2020 - 12/2019
2	gadoterate meglumineIBA 01/2020 - 09/2011
2	EnzymesIBA 09/2018 - 01/2017
2	SolventsIBA 08/2018 - 05/2014
2	Dihydrotachysterol (AT 10)IBA 08/2017 - 03/2009
2	AcidsIBA 01/2016 - 07/2007
2	Radioisotopes (Radionuclides)IBA 01/2016 - 07/2010
2	protohypericinIBA 01/2016 - 09/2015
2	dihydroxydianthroneIBA 11/2015 - 05/2014
2	SolutionsIBA 10/2015 - 09/2011
2	Herbal TeasIBA 08/2015 - 12/2013
2	Apolipoprotein B-48IBA 08/2015 - 05/2015
2	Lipoproteins (Lipoprotein)IBA 05/2015 - 04/2008
2	Sodium CholateIBA 05/2015 - 05/2014
2	microplasminIBA 08/2007 - 10/2004
2	AlbuminsIBA 08/2005 - 05/2005
1	Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric 03/2022
1	Lipid Bilayers (Lipid Bilayer)IBA 01/2022
1	Excipients (Suspending Agents)IBA 04/2021
1	CyclodextrinsIBA 04/2021
1	ginsenoside RdIBA 03/2021
1	technetium Tc 99m glucarateIBA 01/2021
1	AlkanesIBA 01/2021
1	Histones (Histone)IBA 01/2021
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2021
1	Chloroquine (Aralen)FDA LinkGeneric 12/2020
1	Antimalarials (Antimalarial Agents)IBA 12/2020
1	Molecular Probes (Molecular Probe)IBA 11/2020
1	N,N'- bis(pyridoxal- 5- phosphate)ethylenediamine- N,N'- diacetic acid (mangafodipir)FDA Link 01/2020
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2020
1	3,3'-diindolylmethane (diindolylmethane)IBA 01/2020
1	Acetic Acid (Vinegar)FDA LinkGeneric 12/2019

Therapy/Procedure

42	Therapeutics 01/2022 - 01/2002
12	Radiotherapy 04/2021 - 01/2012
9	Radiofrequency Ablation 06/2020 - 01/2002
7	Intravenous Injections 08/2016 - 09/2003
6	Aftercare (After-Treatment) 01/2020 - 03/2005
6	Precision Medicine 05/2019 - 01/2012
3	Drug Therapy (Chemotherapy) 01/2020 - 03/2016
3	Intravenous Administration 11/2017 - 01/2009
2	Laparotomy 08/2016 - 08/2005
2	Traditional Medicine (Folk Remedies) 05/2015 - 12/2013
2	Catheters 12/2013 - 10/2008
1	Off-Label Use 12/2020
1	Electrodes (Electrode) 06/2020